醋酸酐对太平洋白对虾(Penaeus vannamei)β-N-乙酰- D-氨基葡萄糖苷酶的抑制动力学

β-N-乙酰-D-氨基葡萄糖苷酶与南美白对虾的食物消化吸收、蜕壳生长有着密切关系. 海水里存在的有机污染物将影响酶生理功能, 从而进一步影响虾的正常蜕壳,严重将导致对虾的死亡. 醋酸酐是常用的有机溶剂, 故本文应用动力学方法研究醋酸酐对南美白对虾β-N-乙酰-D-氨基葡萄糖苷酶催化pNP-NAG水解时酶活力的变化规律. 表明在醋酸酐浓度低于20.0 mmol/L, 酶的抑制作用是可逆的, 测得醋酸酐对酶抑制的IC50为9.0 mmol/L. 用双倒数作图法测定醋酸酐与游离酶(E)和酶-底物络合物(ES)的结合平衡常数, 结果显示醋酸酐是酶的非竞争性抑制剂. 用底物反应动力学方法观测在不同底物浓度下酶在0.0、3.0、6.0、9.0、12.0 mmol/L的醋酸酐溶液中的失活过程,分别测定了酶的微观失活速度常数k+0及复活速度常数k-0, 结果表明醋酸酐对酶的影响是快速结合再缓慢失活的过程. 比较微观失活速度常数k+0及复活速度常数k-0, 结果暗示在高浓度的醋酸酐溶液中, 酶将完全失活.     

银离子对辣根过氧化物酶的影响

实验研究Ag 对HRP的影响对检测银的污染有重要意义。以ABTS[2,2-连氮-双-(3-乙基苯并噻唑-6-磺酸)]和H2O2为底物,在pH值5.0的条件下,用分光光度法考察了Ag 存在下的辣根过氧化物酶催化氧化反应。Ag 对辣根过氧化物酶的催化活性显示出抑制作用,并进一步分别探讨了对两种底物的抑制类型和对酶结构的影响。结果表明Ag 对底物H2O2而言,对酶的抑制效应属于反竞争性抑制类型,抑制常数Ki=14.83mmol/L;对底物ABTS而言,对酶的抑制效应属于非竞争性抑制,抑制常数Ki=16.139mmol/L。不同浓度Ag 分别与酶作用后,测定酶的内源荧光光谱。光谱结果表明Ag 影响酶活性的同时也影响酶的构象。     

太平洋白对虾(Penaeus vannamei)β-N-乙酰-D-氨基葡萄糖苷酶在二甲亚砜溶液中的失活动力学(英文)

应用动力学方法研究了太平洋白对虾(Penaeusvannamei)β-N-乙酰-D-氨基葡萄糖苷酶在二甲亚砜溶液中以pNP-β-D-GlcNAc为底物时酶活力的变化规律.表明酶在DMSO浓度低于4.20mol/L,酶的失活过程是可逆的,DMSO并不造成酶绝对量的减少,仅对酶的活力发生可逆的下降.测得DMSO对酶抑制的IC50为1.2mol/L.观测了在不同底物浓度下NAGase在0、0.35、0.70、1.05、1.40、1.75mol/L的DMSO溶液中的失活过程,分别测定了游离酶(E)和酶-底物络合物(ES)的微观失活速度常数k+0和k′+0比较结果(k+0值远远大于k′+0)表明,在DMSO溶液中游离酶比酶-底物络合物更易失活,即底物的存在对于酶被DMSO的失活具有明显的保护作用.随着DMSO浓度的增加,游离酶的逆向微观复活速度常数k-0却不断降低,说明在高浓度DMSO环境中,NAGase可逆恢复的能力逐渐微弱.     

基因工程菌1016氨基酰化酶的酶学性质研究

研究了基因工程菌 1 0 1 6所产的氨基酰化酶的酶学特性。该酶的拆分速率符合米氏方程 ,且在 0 .5mol/L的高底物浓度下 ,无底物抑制现象。 37℃时的米氏常数和最大反应速率分别为 0 .0 4 8mmol/L和 2 .1 78mmol/L·h。最适反应温度为 5 5℃。5 5℃时 ,Km为 0 .0 37mmol/L ,Vmax为 2 .5 5 8mmol/L·h。最适底物为乙酰蛋氨酸 ;热稳定性好。     

乙酰胆碱酯酶的别构作用:两类胆碱能配基在外周阴离子部位的颉颃

纯化的黄姑鱼肌肉乙酰胆碱酯酶,在低离子强度介质中,底物(硫代丁酰胆碱)浓度和活性的关系符合Michaelis方程。底物在外周阴离子部位的结合不抑制酶活性。然而,底物按Kss值(底物在外周结合作用的解离常数)解除箭毒和阿托品对酶的纯非竞争性抑制作用。与箭毒类似的胆碱能配基还有1,5-双-(4-三甲铵苯)戍酮-3及十甲鎓。但它们对酶的催化阴离子部位也有很高的亲和力。我们测定了它们作用于酶上两类部位的抑制常数。另一类胆碱能配基,包括硫代丁酰胆碱、乙酰胆碱、苯酰胆碱、间-三甲铵酚、烟碱、六甲鎓和季铵酚,除了它们在酶的催化阴离子部位有较高的亲和力外,也结合于外周部位,并表现为解除箭毒抑制的颉颃作用。其中某些化合物在外周结合后也有别构激活作用。从这些结果能假定,酶至少可存在三种构象状态。讨论了乙酰胆碱酯酶和乙酰胆碱受体的某些相似性。     

乙酰胆碱酯酶的别构作用:两类胆碱能配基在外周阴离子部位的颉颃

纯化的黄姑鱼肌肉乙酰胆碱酯酶,在低离子强度介质中,底物(硫代丁酰胆碱)浓度和活性的关系符合Michaelis 方程。底物在外周阴离子部位的结合不抑制酶活性。然而,底物按Kss 值(底物在外周结合作用的解离常数)解除箭毒和阿托品对酶的纯非竞争性抑制作用。与箭毒类似的胆碱能配基还有1,5-双-(4-三甲铵苯)戊酮-3及十甲鎓。但它们对酶的催化阴离子部位也有很高的亲和力。我们测定了它们作用于酶上两类部位的抑制常数。另一类胆碱能配基,包括硫代丁酰胆碱、乙酰胆碱、苯酰胆碱、间-三甲铵酚、烟碱、六甲鎓和季铵酚,除了它们在酶的催化阴离子部位有较高的亲和力外,也结合于外周部位,并表现为解除箭毒抑制的颉颃作用。其中某些化合物在外周结合后也有别构激活作用。从这些结果能假定,酶至少可存在三种构象状态。讨论了乙酰胆碱酯酶和乙酰胆碱受体的某些相似性。     

三甲基苯基磷酸酯对神经毒性酯酶的抑制及其酶促动力学分析

以可使人和敏感动物产生迟发性神经毒性的有机磷化合物三甲基苯基磷酸酯（TOCP）为测试药物,研究其在体外对成年产卵来航母鸡不同神经组织神经毒性酯酶（NTE）活性抑制的敏感性及其抑制的动力学．结果表明,外周神经NTE对于TOCP的抑制比中枢神经NTE敏感得多．TOCP对鸡脑、脊髓和坐骨神经中NTE抑制的I50值．分别为：1．9323、2．3950和0．0035mmol／L．NTE酶促动力学研究显示,鸡脑NTE催化分解底物戊酸苯酯（PV）的Vmax为62．10nmol·min-1·mg-1,Km为0．92mmol／L．TOCP对鸡脑NTE的抑制属竞争性抑制类型,并有"底物抑制"现象．     

OPTA对乳酸脱氢酶的抑制动力学

邹承鲁建立的酶活性不可逆改变动力学理论已为实验所验证,它不仅适用于单底物酶的抑制和激活的动力学研究,而且也适用于双底物酶反应系统.但在双底物酶反应系统中,底物和酶的结合方式有四种机制,即随机机制、有序机制、强制有序机制和乒乓机制,迄今为止这一动力学方法仅对随机机制的肌酸激酶进行了实验研究.而其它机制的实验研究尚未见诸报道.我们选用了有序机制的乳酸脱氢酶(LDH),用邻苯二甲醛(OPTA)为抑制剂对该酶的抑制过程进行了实验研究.结果表明,OPTA对该酶的抑制为不可逆抑制.其产物生成与时间的关系曲线符合邹氏方程:[P]=[P]_x(1-e~(-A[OPTA]).由ln([P]_x-[P])对t作图为一直线,表明它的抑制作用为单相动力学过程,抑制剂与酶的结合为一步反应.由直线的斜率A[OPTA]对[OPTA]作图为一过原点的直线.说明表观速度常数A与OPTA的浓度无关.OPTA与酶的结合为非络合型.测得的OPTA与EE-NADH结合的微观速度常数分别为:K(?)=49.6(mmol L)~(-1)min,(?)=2.31(mmol L)min~(-1)(?).明显小于(?)的事实表明.NADH对失活有明显的保护作用.OPTA是一个竞争性的不可逆抑制剂.用传统的方法测得的(?)为42.5(mmol L)min~(-1).与邹氏方法测得的结果非常接近.     

拟除虫菊酯对家蝇Ca—ATPase和Ca—Mg—ATPase的抑制作用

通过对家蝇神经系统的Ca-ATPase、Ca-Mg-ATPase性质的研究,表明Ca-ATPase、Ca-Mg-AT-Pase反应的适宜pH值分别为7.0-8.5和6.5。适温皆为35-40℃;底物（ATP）最适浓度均为0.5mmol/L。比较测定了家蝇三个品系中两种ATPase的活性及拟除虫菊酯对该酶的抑制作用,实验证明,敏感与Del-R、2Cl-R品系间Ca-ATPase、Ca-Mg-ATPase活力无明显的差异。溴氰菊酯、氯菊酯可部分地抑制敏感品系家蝇Ca-ATPase活性,而对拟除虫菊酯抗性品系Ca-ATPase无抑制作用,从而证明,Del-R、2Cl-B品系Ca-ATPase对拟除虫菊酯的敏感性已明显降低,这可能能是击倒抗性机制之一。实验还表明,拟除虫菊酯对Ca-Mg-ATPase基本上无抑制作用,这说明在家蝇中,Ca-Mg-ATPase并不是拟除虫菊酯的一个靶标位点。     

壳聚糖的特性对吲哚美辛微囊性能的影响

本研究利用自制的壳聚糖与阿拉伯胶为壁材,以戊二醛为固化交联剂,通过复凝法制备吲哚美辛载药微囊;研究了不同分子量、不同脱乙酰度的壁材壳聚糖对所形成微囊的性能的影响.结果表明:不同脱乙酰度与不同分子量的壳聚糖所制的载药微囊包封率、载药量、粒径、吸水溶胀性能等都有一定差别,体外溶出实验表明他们缓释与控释性能也有不同.     

Investigation of the Effects of Some Drugs and Phenolic Compounds on Human Dihydrofolate Reductase Activity

Dihydrofolate reductase (DHFR) plays a fundamental role in cellular metabolism and cell growth. Inhibition of this enzyme will cause a decrease in the amount of folate that occurs in many metabolic processes, and the deficiency of which may cause various diseases. This study investigated the effects of some drugs and phenolic compounds on DHFR activity in vitro. To determine the inhibitory effect of compounds, enzyme activity was measured with a final concentration of an inhibitor ranging from 10 μM to 51 mM. DHFR was inhibited effectively by naringin, ferulic acid, and levofloxacin with IC₅₀ values under 660 μM. Syringic acid, cefepime, ceftizoxime, cefazolin, ceftriaxone, and ceftazidime exhibited inhibitory effects on the enzyme activity with IC₅₀ values in the range of 3.840–30.224 mM. K_i constants were calculated using the Cheng–Prusoff equation. K_i constants calculated in the range of 0.009–2.024 mM with respect to nicotinamide adenine dinucleotide phosphate oxidase (NADPH) and in the range of 0.060–5.830 mM about FH₂.     

Effect of the non-steroidal anti-inflammatory drugs on the acyl-CoA synthetase activity toward medium-chain,long-chain and polyunsaturated fatty acids in mitochondria of mouse liver and brain

Effect of eleven non-steroidal anti-inflammatory drugs on the acyl-CoA synthetase activities toward octanoic, palmitic, arachidonic and docosahexaenoic acids was evaluated in mouse liver and brain mitochondria. The drugs tested were aspirin, salicylic acid, diflunisal, mefenamic acid, indomethacin, etodolac, ibuprofen, ketoprofen, naproxen, loxoprofen, flurbiprofen. In mouse liver mitochondria, diflunisal and mefenamic acid exhibited the inhibitory activities not only for octanoic acid (IC₅₀?=?78.7 and 64.7 µM) and but also for palmitic acid (IC₅₀?=?236.5 and 284.4 µM), respectively. Aspirin was an inhibitor for the activation of octanoic acid only (IC₅₀?=?411.0 µM). In the brain, mefenamic acid and diflunisal inhibited strongly palmitoyl-CoA formation (IC₅₀?=?57.3 and 114.0 µM), respectively. The activation of docosahexaenoic acid in brain was sensitive to inhibition by diflunisal and mefenamic acid compared with liver.     

Prostaglandin biosynthesis in rabbit kidney medulla: Inhibition vs. by aspirin, indomethacin and meclofenamic acid

The non-steroidal anti-inflammatory drugs aspirin, indomethacin and meclofenamic acid were compared for their potency and duration of inhibition of prostaglandin biosynthesis in rabbit kidney medulla. Indomethacin and meclofenamic acid showed equal potency of inhibition (IC₅₀ 0.88 μM and 0.85 μM respectively) while aspirin was a much weaker inhibitor (IC₅₀ 120 μM). , indomethacin was the most powerful inhibitor (ID₅₀ 0.034 mg/kg) followed by meclofenamic acid (0.45 mg/kg) and aspirin (2.35 mg/kg).Studies on the duration of inhibition by these compounds showed the effect of indomethacin and meclofenamic acid to be completely reversed within 4–6 hours. In contrast, return of kidney prostaglandin biosynthetic activity following aspirin inhibition is very slow and significant inhibition is still present 48 hours after a single aspirin injection. The inhibitory effect of aspirin could be blocked by pretreatment with indomethacin, indicating that both drugs interact with related sites on the cyclo-oxygenase enzyme. The irreversible inhibition of the cyclo-oxygenase by aspirin as demonstrated in studies of other investigators suggests that the return of kidney prostaglandin synthetase activity after aspirin inhibition represents synthesis of new cyclo-oxygenase protein.     

Synthesis and biological evaluation of 1-(benzenesulfonamido)-2-[5-(N-hydroxypyridin-2(1H)-one)]acetylene regioisomers: a novel class of 5-lipoxygenase inhibitors

A hitherto unknown class of linear acetylene regioisomers were designed such that a SO₂NH₂ group was located at the ortho-, meta-, or para-position of the acetylene C-1 phenyl ring, and a N-hydroxypyridin-2(1H)-one moiety was attached via its C-5 position to the C-2 position on an acetylene template (scaffold). All three regioisomers inhibited 5-lipoxygenase (5-LOX), where the relative potency order was 2-SO₂NH₂ (IC₅₀ = 10 μM) >3-SO₂NH₂ (IC₅₀ = 15 μM) >4-SO₂NH₂ (IC₅₀ = 68 μM) relative to the reference drug nordihydroguaiaretic acid (NDGA; IC₅₀ = 35 μM). The 2-SO₂NH₂ regioisomer (ED₅₀ = 86.0 mg/kg po) exhibited excellent oral anti-inflammatory (AI) activity that was more potent than aspirin (ED₅₀ = 128.9 mg/kg) and marginally less potent than ibuprofen (ED₅₀ = 67.4 mg/kg). The N-hydroxypyridin-2(1H)one moiety provides a novel pharmacophore for the design of cyclic hydroxamic mimetics capable of chelating 5-LOX iron for exploitation in the design of 5-LOX inhibitory AI drugs.     

Effects of some analgesic anaesthetic drugs on human erythrocyte glutathione reductase: an in vitro study

Inhibitory effects of some analgesic and anaesthetic drugs on human erythrocyte glutathione reductase were investigated. For this purpose, human erythrocyte glutathione reductase was initially purified 2139-fold in a yield of 29% by using 2′, 5′-ADP Sepharose 4B affinity gel and Sephadex G-200 gel filtration chromatography. SDS polyacrylamide gel electrophoresis confirmed the purity of the enzyme by sharing a single band. A constant temperature (+4°C) was maintained during the purification process. Diclofenac sodium, ketoprofen, lornoxicam, tenoxicam, etomidate, morphine and propofol exhibited inhibitory effects on the enzyme in vitro using the Beutler assay method.

K_i constants and IC₅₀ values for drugs were determined from Lineweaver-Burk graphs and plotting activity % versus [I] graphs, respectively. The IC₅₀ values of diclofenac sodium, ketoprofen, lornoxicam, propofol, tenoxicam, etomidate and morphine were 7.265, 6.278, 0.3, 0.242, 0.082, 0.0523 and 0.0128 mM and the K_i constants were 23.97 ± 2.1, 22.14 ± 7.6, 0.42 ± 0.18, 0.418 ± 0.056, 0.13 ± 0.025, 0.0725 ± 0.0029 and 0.0165 ± 0.0013 mM, respectively. While diclofenac sodium, ketoprofen, lornoxicam, tenoxicam etomidate and morphine showed competitive inhibition, propofol displayed noncompetitive inhibition.     

Intracellular lactate dehydrogenase concentration as an index of cytotoxicity in rat hepatocyte primary culture

In searching for a reliable index for cytotoxicity testing in rat hepatocyte primary culture, lactate dehydrogenase (LDH) concentrations in lysates of attached hepatocytes and LDH released into the culture medium were compared under conditions of exposure to various dosages of sodium chloride, sodium salicylate, R-warfarin, acetaminophen, phenylbutazone, and furosemide (frusemide). The amount of intracellular LDH was assessed by inducing the cells to release the enzyme with 0.1% Tritron X-100. The induced LDH leakage was completed in 1 hr and the LDH activity was stable in storage at 10° for 2 weeks. We found that intracellular LDH is a direct indicator of the number of viable hepatocytes in contrast to the LDH released, because released LDH does not account for the significant number of cells detached from monolayer but which are not leaky, during the 6-hr test period. Based on IC₅₀ values (50% inhibitory concentration), the relative cytotoxicities are R-warfarin > phenylbutazone > furosemide > acetaminophen > sodium salicylate > sodium chloride.Abbreviations DMSO dimethyl sulfoxide - HPC hepatocyte primary culture - IC₅₀ 50% inhibitory concentration - LDH lactate dehydrogenase     

Synthesis of New Ester Derivatives of Salicylic Acid and Evaluation of Their COX Inhibitory Potential

Salicylic acid is an NSAID with serious side effects on the GIS. The side effects of salicylic acid on the GIS are slightly reduced by acetylating salicylic acid. 12 new ester analogs of salicylic acid were synthesized with high yields in this study. The chemical structures of the synthesized compounds were characterized by ¹H-NMR, ¹³C-NMR, and HRMS spectra. The inhibitory potential of the compounds was evaluated on COXs by in vitro and in silico studies. The COX2 inhibitory activity of the most potent inhibitor MEST1 (IC₅₀: 0.048 μM) was found to be much higher than the COX2 inhibitory activity of aspirin (IC₅₀: 2.60 μM). In docking studies, the strongest inhibitor among the compounds synthesized was predicted to be MEST1, with the lowest binding energy. Docking studies revealed that MEST1 extends from the hydrophobic channel to the top of the cyclooxygenase active site, forming various interactions with residues in the binding pocket.     

Preparation and characterization of novel bioactive peptides responsible for angiotensin I‐converting enzyme inhibition from wheat germ

Reported is the preparation of wheat germ (WG) hydrolyzate with potent angiotensin I‐converting enzyme (ACE) inhibitory activity, and the characterization of peptides responsible for ACE inhibition. Successful hydrolyzate with the most potent ACE inhibitory activity was obtained by 0.5 wt.%–8 h Bacillus licheniformis alkaline protease hydrolysis after 3.0 wt.%–3 h α‐amylase treatment of defatted WG (IC₅₀; 0.37 mg protein ml⁻¹). The activity of WG hydrolyzate was markedly increased by ODS and subsequent AG50W purifications (IC₅₀; 0.018 mg protein ml⁻¹). As a result of isolations by high performance liquid chromatographies, 16 peptides with the IC₅₀ value of less than 20 μm , composed of 2–7 amino acid residues were identified from the WG hydrolyzate. Judging from the high content (260 mg in 100 g of AG50W fraction) and powerful ACE inhibitory activity (IC₅₀; 0.48 μm ), Ile‐Val‐Tyr was identified as a main contributor to the ACE inhibition of the hydrolyzate. Copyright © 1999 European Peptide Society and John Wiley & Sons, Ltd.     

Variability in blood platelet inhibitory activity of Allium (Alliaceae) species accessions

In the past 20 yr, the presence of blood platelet inhibitory activity in plant species from the genus Allium has been confirmed by a range of clinical and in vitro investigations. Although a number of Allium species have been identified as possessing antiplatelet properties, little is known of the variability for this trait among accessions in these species. Experiments were conducted to assess variability in antiplatelet activity of 58 Allium (Alliaceae) accessions. Extracts were prepared from a diverse collection of 16 Allium species accessions, 33 cultivated accessions of Allium cepa including standard cultivars, inbred lines, and open-pollinated populations, and nine Allium cepa plant introductions of diverse origin. Platelet inhibitory activity was determined via a platelet aggregation assay with human platelet-rich plasma. Relative in vitro inhibition of platelet aggregation was measured for each accession and control samples, and inhibition constants (IC₅₀) were calculated. Dose-dependent inhibition was observed and measured for each Allium accession. Significant (P < 0.01) IC₅₀ variability was detected among accessions, with the lowest accession IC₅₀ values exhibiting nearly 50-fold greater inhibition of aggregation than the highest accession IC₅₀ values. IC₅₍₎ variability among Allium cepa accessions was ≈ 12 times less than among Allium species accessions. Results from this investigation demonstrate substantial variability for efficacy of the antiplatelet factor among Allium accessions.     

Inhibitory effects of Cefazolin and Cefodizime on the activity of mushroom tyrosinase

Tyrosinase (EC 1.14.18.1) catalyzes both the hydroxylation of tyrosine into o-diphenols and the oxidation of o-diphenols into o-quinones that form brown or black pigments. In the present paper, the effects of Cefazolin and Cefodizime on the activity of mushroom tyrosniase have been studied. The results showed that the Cephalosporin antibacterial drugs (Cefazolin and Cefodizime) could inhibit both monophenolase activity and diphenolase activity of the enzyme. For the monophenolase activity, Both Cefazolin and Cefodizime could lengthen the lag time and decrease the steady-state activities, and the IC₅₀ values were estimated as 7.0 mM and 0.13 mM for monophenolase activity, respectively. For the diphenolase activity, the inhibitory capacity of Cefodizime was obviously stronger than that of Cefazolin, and the IC₅₀ values were estimated as 0.02 mM and 0.21 mM, respectively. Kinetic analyses showed that inhibition by both compounds was reversible and their mechanisms were competitive and mixed-type, respectively. Their inhibition constants were also determined and compared. The research may offer a lead for designing and synthesizing novel and effective tyrosinase inhibitors and also under the application field of Cephalosporins.